果冻影院

XClose

果冻影院 News

Home
Menu

Stem cells collected in late pregnancy herald advances in prenatal medicine

4 March 2024

A pioneering approach, developed by researchers at 果冻影院 and Great Ormond Street Hospital (GOSH), means human development can be observed in late pregnancy for the first time, raising the possibility of monitoring and treating congenital conditions before birth.

Kidney organoid grown from fetal stem cells

The study, , documents the first time that complex cell models, called organoids, have been grown from human stem cells during an active pregnancy. These 鈥榤ini-organs鈥 also retain the baby鈥檚 biological information.

Organoids provide researchers with invaluable tools to study how organs function both when they are healthy and when impacted by disease.

The researchers say the stem cell organoids will facilitate monitoring of fetal development in late pregnancy, modelling of disease progression and testing of new treatments for diseases such as congenital diaphragmatic hernia (CDH).

Until now, organoids have been derived from adult stem cells or post-termination fetal tissue1. Regulations also restrict when fetal samples can be obtained. In the UK this can be done up to 22 post-conception weeks, the legal limit for the termination of a pregnancy, but in countries like the US fetal sampling is illegal.

These restrictions have so far limited organoids鈥 utility for studying normal human development past 22 weeks, as well as congenital diseases at a point when there may still be an opportunity to treat them.

To overcome these issues, researchers at 果冻影院 and GOSH hypothesised that it may be possible to grow organoids from stem cells that have passed into the amniotic fluid, which surrounds the child in the womb and protects it during pregnancy. Because the child would not be touched during the collection process, sampling restrictions would be overcome and the cells would carry the same biological information as the child.

In this study, researchers extracted and characterised live cells from amniotic fluid samples taken from 12 pregnancies as part of routine diagnostic testing2. They then used single-cell RNA sequencing to identify which tissues these stem cells came from. Stem cells from the lungs, kidneys and intestine were successfully extracted, which were used to grow organoids that had functional features of these tissue types.

MediaCentral Widget Placeholder

Video: lung organoids showing movement of cilia, hair-like structures in the lung.

Dr Mattia Gerli, first author of the study from 果冻影院 Surgery & Interventional Science, said: 鈥淭he organoids we created from amniotic fluid cells exhibit many of the functions of the tissues they represent, including gene and protein expression. They will allow us to study what is happening during development in both health and disease, which is something that hadn鈥檛 been possible before. We know so little about late human pregnancy, so it鈥檚 incredibly exciting to open up new areas of prenatal medicine.鈥

To assess how the organoids might be used in the management of congenital diseases, the team worked with researchers at KU Leuven in Belgium to study the development of babies with CDH, a condition where a hole in the diaphragm means organs like the intestine and liver get displaced into the chest, putting pressure on the lungs and hindering healthy growth.

Organoids from babies with CDH both pre- and post-treatment were compared to organoids from healthy babies to study the biological characteristics of each group. As expected, there were significant developmental differences between the healthy and pre-treatment CDH organoids. But the organoids in the post-treatment CDH group were much closer to healthy ones, providing an estimate of the treatment鈥檚 effectiveness at a cellular level.

NIHR Professor Paolo de Coppi, senior author of the study from 果冻影院 Great Ormond Street Institute of Child Health and Great Ormond Street Hospital, said: 鈥淭his is the first time that we鈥檝e been able to make a functional assessment of a child鈥檚 congenital condition before birth, which is a huge step forward for prenatal medicine. Diagnosis is normally based on imaging such as ultrasound or MRI and genetic analyses.

鈥淲hen we meet families with a prenatal diagnosis, we鈥檙e often unable to tell them much about the outcome because each case is different. We鈥檙e not claiming that we can do that just yet, but the ability to study functional prenatal organoids is the first step towards being able to offer a more detailed prognosis and, hopefully, provide more effective treatments in future.鈥

This research was supported by the National Institute for Health and Care Research (NIHR) and Wellcome.

Links听

Image

  • Kidney organoid. Credit:听Giuseppe Cal脿, Paolo De Coppi and Mattia Gerli/果冻影院.

Media contact听

Dr Matt Midgley

E: m.midgley [at] ucl.ac.uk